O‐GlcNAc modification has the potential to impair insulin receptor signaling as insulin receptor substate‐1 (IRS‐1) (Ser1101) and IRS‐2 (Ser1149) become glycosylated following an increase in UDP‐GlcNAc pools, contributing to insulin resistance.111. Here, INSR is linked to Insulin resistance.